16:09 EST Cadrenal Therapeutics (CVKD) files to sell 590K shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
- Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
- Cadrenal Therapeutics Advances Tecarfarin Development
- Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
- Cadrenal Therapeutics raises $5.1M via at-the-market facility
- Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy